Clonidine is an imidazole derivate that acts as an agonist of alpha-2 adrenoceptors. This activity is useful for the treatment of hypertension, severe pain, and ADHD.
Clonidine was granted FDA approval on 3 September 1974.
Clonidine tablets and transdermal systems are indicated for the treatment of hypertension alone or in combination with other medications. A clonidine injection is indicated for use with opiates in the treatment of severe cancer pain where opiates alone are insufficient. An extended release tablet of clonidine is indicated for the treatment of ADHD either alo...
London Health Sciences Centre, London, Ontario, Canada
McMaster Children's Hospital/Hamilton Health Sciences, Hamilton, Ontario, Canada
Mayo Clinic, Rochester, Minnesota, United States
Santa Casa de Belo Horizonte Hospital, Belo Horizonte, Minas Gerais, Brazil
Creighton Community Health Center, Omaha, Nebraska, United States
Department of Anaesthesiology and Intensive Care Medicine, University of Schleswig-Holstein Campus Kiel, Kiel, Germany
Mayo Clinic, Rochester, Minnesota, United States
UIHC, Iowa City, Iowa, United States
Shriners Hospital for Children; Shriners Burns Hospital, Galveston, Texas, United States
Department of Advanced Medical and Surgical Sciences, Università della Campania "Luigi Vanvitelli", Naples, Italy, Naples, Italy
Henri Jacques CLEMENT, Lyon, France
Anesthesie Reanimation - Gynecologie - Hopital de La Croix Rousse, Lyon, France
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.